Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Operating Expenses: 2009-2024

Historic Operating Expenses for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to $11.7 million.

  • RedHill Biopharma's Operating Expenses fell 48.20% to $4.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $27.4 million, marking a year-over-year decrease of 41.47%. This contributed to the annual value of $11.7 million for FY2024, which is 44.59% down from last year.
  • RedHill Biopharma's Operating Expenses amounted to $11.7 million in FY2024, which was down 44.59% from $21.2 million recorded in FY2023.
  • Over the past 5 years, RedHill Biopharma's Operating Expenses peaked at $61.9 million during FY2021, and registered a low of $11.7 million during FY2024.
  • Its 3-year average for Operating Expenses is $23.6 million, with a median of $21.2 million in 2023.
  • In the last 5 years, RedHill Biopharma's Operating Expenses spiked by 47.76% in 2021 and then crashed by 44.59% in 2024.
  • Yearly analysis of 5 years shows RedHill Biopharma's Operating Expenses stood at $41.9 million in 2020, then soared by 47.76% to $61.9 million in 2021, then slumped by 38.57% to $38.0 million in 2022, then crashed by 44.23% to $21.2 million in 2023, then tumbled by 44.59% to $11.7 million in 2024.